🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Spain / NCT06775028
Recruiting Not applicable

Integrated Approach in Frail Older People with Atrial Fibrillation

NCT06775028 · tracked via the Priya Life Science Spain tracker
Phase
Not applicable
Started
2024-04-11
Last updated
2025-01-14

Condition(s) studied

Atrial Fibrillation (AF)HypertensionCoronary Arterial Disease (CAD)Heart FailureCOPDPeripheral Arterial DiseaseCKDDiabetes MellitusStrokeTIA (Transient Ischemic Attack)

Investigational drug(s) / intervention(s)

iABC platform use

iABC platform use: The novel platform (iABC) that will be used in AFFIRMO will consist of an educational program, a healthy or functional diet/physical activity, guideline-adherent drug treatments, periodic (re)assessment.

Study summary

The study will verify if a structured multidisciplinary approach (called iABC), aimed to improve the appropriate management of elderly AF patients with multimorbidity (the i-ABC group), would provide a clear evidence of an improvement in clinical conditions and quality of life compared to usual clinical care. The i-ABC group in AFFIRMO will follow the ABC pathway, focused on three domains: avoid stroke with anticoagulation (with optimized VKA or label-adherent DOAC use); better symptom management; and optimized management of associated cardiovascular and non cardiovascular comorbidities.

The study will be conducted in Bulgaria, Denmark, Italy, Romania, Serbia and Spain .

Eligibility

Sex
ALL
Min age
65 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Outpatients of both sexes with age ≥65 years; * First diagnosed, paroxysmal, persistent, long-standing persistent or permanent AF, confirmed as per guideline-recommended diagnostic criteria for AF, e.g. with electrocardiogram (ECG) or Holter monitoring; * ≥1 additional long-term comorbidity, thus fulfilling the definition of multimorbidity: hypertension (treated with at least 2 antihypertensive drugs), coronary artery disease (CAD), peripheral artery disease, heart failure, stroke/TIA, diabetes mellitus, COPD, CKD. Exclusion Criteria: * Mechanical prosthetic heart valve or moderate/severe mitral stenosis; * Patient unwilling to be enrolled and sign written informed consent; * Patient unable to understand the study and attend the follow-up; * Serious diseases with a life expectancy inferior to 12 months; * Patients included in other interventional studies. Only for sites randomized to the iABC group: \- Patient without a device suitable for iABC use.

Primary outcome measure(s)

Trial sites (50)

FacilityCityRegionStatus
MHAT Haskovo AD-Cardiology Haskovo Bulgaria Recruiting
SHATS Sveti Georgi - Pernik-Cardiology Pernik Bulgaria Recruiting
MBAL Sv. Ivan Rilski-Cardiology Plovdiv Bulgaria Recruiting
UMBAL Sveti Georgi EAD-Clinic of Cardiology Plovdiv Bulgaria Recruiting
UMHAT Pulmed Plovdiv-Cardiology Plovdiv Bulgaria Recruiting
Acibadem City Clinic Tokuda Hospital-Dept of Electrophysiology Clinic of Cardiology Sofia Bulgaria Recruiting
Acibadem City Clinic UMBAL Cardiovascular Center-CARDIOLOGY Sofia Bulgaria Recruiting
National Heart Hospital-ICCU Sofia Bulgaria Recruiting
Herlev Hospital-Department of Cardiology Herlev Denmark Recruiting
North Denmark Regional Hospital-Department of Cardiology Hjørring Denmark Recruiting
Horsens Regional Hospital-Department of Medicine Horsens Denmark Recruiting
Silkeborg Regional Hospital-Diagnostic Centre, University Clinic for Development of Innovative Patient Pathways Silkeborg Denmark Recruiting
Azienda Ospedaliera S. Anna E S. Sebastiano-Cardiologia Clinica Universitaria Caserta CE Recruiting
Ospedale Santa Maria Nuova-Cardiologia - Firenze 1 Florence FI Recruiting
Als Genovese Palazzo Della Salute-Cardiologia Quarto Genova GE Recruiting
Ospedale Della Misericordia-U.O. Di Cardiologia Grosseto GR Recruiting
Fondazione Irccs San Gerardo Dei Tintori - Ospedale San Gerardo - U.O.C. Cardiologia Monza MB Recruiting
Istituti Clinici Scientifici Maugeri Irccs Sede Di Milano-Uo Cure Subacute Milan MI Recruiting
Ospedale Civile 'Guglielmo Da Saliceto'-Uoc Cardiologia E Utic Piacenza PC Recruiting
Ospedale Gubbio-Gualdo Tadino-U.O. Di Utic E Cardiologia Gubbio PG Recruiting
Policlinico Umberto Primo-Medicina Interna E Immunologia Clinica Roma RM Recruiting
Azienda Ospedaliera Santa Maria-Medicina Interna Terni TR Recruiting
Pou "Santa Maria Della Misericordia"-S.O.C. Cardiologia Udine UD Recruiting
Aou Federico Ii-Medicina Metabolico-Riabilitativa Naples Italy Recruiting
Spitalul Clinic Colentina-Cardiology Bucharest Romania Recruiting
Spitalul Clinic Colentina-Internal Medicine Bucharest Romania Recruiting
Spitalul Clinic Coltea-Internal Medicine and Cardiology Bucharest Romania Recruiting
Spitalul Clinic de Urgenta 'Bagdasar-Arseni'-Cardiology Bucharest Romania Recruiting
Spitalul Clinic de Urgenta Bucuresti-Cardiology Bucharest Romania Recruiting
Spitalul Clinic Prof.Dr.Th.Burghele-Internal Medicine and Cardiology Bucharest Romania Recruiting
Spitalul Universitar de Urgenta Elias-Cardiology Bucharest Romania Recruiting
Spitalul Universitar de Urgenta Militar Central Dr. Carol Davila-Cardiac Function Laboratory Bucharest Romania Recruiting
Institute for Cardiovascular Diseases Dedinje-Pacemaker and electrophysiology department Belgrade Serbia Recruiting
KBC Bezanijska Kosa-Cardiology Department Belgrade Serbia Recruiting
KBC Zemun-Cardiology Department Belgrade Serbia Recruiting
University Clinical Centre of Serbia-Department for cardiac arrhythmias Belgrade Serbia Recruiting
University Clinical Centre of Serbia-Department for invasive electrophysiology Belgrade Serbia Recruiting
University Clinical Centre of Serbia-Emergency centre Belgrade Serbia Recruiting
University Clinical Centre of Kragujevac-Cardiology Department Kragujevac Serbia Recruiting
University Clinical Centre of Nis-Cardiology Department Niš Serbia Recruiting

+ 10 more sites — see the full list on the official registry below.

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06775028 on ClinicalTrials.gov ↗ ← All trials in Spain